Irach Taraporewala
Vorstandsvorsitzender bei EOM PHARMACEUTICALS HOLDINGS, INC.
Ursprung des Netzwerks ersten Grades von Irach Taraporewala
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.
9
| Extinct | Pharmaceuticals: Major | 9 |
Advanced Viral Research Corp.
 Advanced Viral Research Corp. Pharmaceuticals: MajorHealth Technology Advanced Viral Research Corp. is a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company was founded in July 1985 and is headquartered in Yonkers, NY.
6
| Private Company | Pharmaceuticals: Major | 6 |
| Public Company | Pharmaceuticals: Major | 6 | |
EOM Pharmaceuticals, Inc.
 EOM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of EOM Pharmaceuticals Holdings, Inc., EOM Pharmaceuticals, Inc. is a privately held, clinical-stage company focused on developing novel drugs to improve the quality of life for patients with debilitating and sometimes deadly diseases. The company is based in Montvale, NJ. The company's mission is to pursue innovative approaches with small molecule therapeutics to address urgent and unmet medical needs. EOM's pipeline includes the development of the first-and-only dual-acting, broad-spectrum immunomodulator EOM613, which has the potential to treat systemic illnesses caused by intense inflammatory immune reactions, including COVID-19, influenza, and cancer cachexia. Additionally, EOM is working on an advanced formulation of EOM147, the first potential topically administered eye drop for treating retinal diseases. The company was founded by Shalom Z. Hirschman and Eli Goldberger, and Irach B. Taraporewala has been the CEO since 2020. EOM Pharmaceuticals was acquired by ImmunoCellular Therapeutics Ltd. on December 02, 2021.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
| Public Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Irach Taraporewala
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| 8X8, INC. | Packaged Software | Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The Retina Society | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
SKS Ocular LLC
 SKS Ocular LLC BiotechnologyHealth Technology SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept. | Biotechnology | Chief Executive Officer Founder Founder | |
| American Society of Retinal Specialists | Corporate Officer/Principal Corporate Officer/Principal | ||
Orphion Therapeutics, Inc.
 Orphion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orphion Therapeutics, Inc. develops novel gene therapies for the treatment of genetic disorders. The private company is based in Great Neck, NY. The company was founded by Samuel I. Backenroth. The CEO is Jason Scott Slakter. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| MARIZYME, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Touro College | College/University | Undergraduate Degree Undergraduate Degree | |
American Ophthalmological Society
 American Ophthalmological Society Miscellaneous Commercial ServicesCommercial Services The American Ophthalmological Society is an organization that aims to promote excellence in patient care, education, and research in the field of ophthalmology. The society is based in San Francisco, CA, and was founded in 1864 by Edward Delafield, Daniel Bennett St. John Roosa, and Henry Noyes. The private company addresses essential issues in medicine and advance the art and science of ophthalmology. The society holds annual meetings every third week of May each year, and they offer travel grants to non-members who wish to attend. Membership nominations are accepted until April 30th each year. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree Corporate Officer/Principal | |
| Macula Society | Corporate Officer/Principal Corporate Officer/Principal | ||
DepYmed, Inc.
 DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Biotechnology | Director/Board Member Founder | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| PROBILITY MEDIA CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
| HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Clinical Supplies Management, Inc.
 Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Clinical Supplies Management, Inc. engages in the provision of clinical trial supply solutions for pharmaceutical and biotechnology companies. Its clinical services include packaging and labeling; storage and global distribution; chain management consulting; and returns, reconciliation, and destruction. The company was founded by Gerald E. Finken in 1997 and is headquartered in Fargo, ND. | Medical/Nursing Services | Director/Board Member | |
| RENOVARO INC. | Biotechnology | Director/Board Member | |
Leading Biosciences, Inc.
 Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Leading Biosciences, Inc. provides healthcare services. It offers therapy for severe sepsis, septic shock, and multi-organ failure. The company was founded by John Rodenrys and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| ENTERO THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| Vitreous Retina Macula Consultants of New York | Corporate Officer/Principal | ||
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PROFIRE ENERGY, INC. | Electronic Equipment/Instruments | President | |
| University of Utah | College/University | Undergraduate Degree | |
| Westminster College (Utah) | College/University | Masters Business Admin | |
| Fairleigh Dickinson University | College/University | Masters Business Admin | |
Utah Valley Chamber of Commerce
 Utah Valley Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Utah Valley Chamber of Commerce is a chamber of commerce organization. The non-profit company is based in Provo, UT. The CEO of the company is Curtis Blair. | Miscellaneous Commercial Services | Director/Board Member | |
Jason S. Slakter MD PC
 Jason S. Slakter MD PC Medical/Nursing ServicesHealth Services Part of ProScan Imaging LLC, Jason S. Slakter MD PC is an ophthalmology imaging core lab. The company is based in Great Neck, NY. The company was founded in 1998 by Jason Scott Slakter and Jeffrey Schneebaum. Jason Scott Slakter has been the CEO since 1998. Jason S. Slakter MD was acquired by WorldCare Clinical LLC on September 03, 2021. | Medical/Nursing Services | Chief Executive Officer | |
| New York University School of Medicine | College/University | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| ZYVERSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Blue Water Acquisition Corp. II
 Blue Water Acquisition Corp. II Financial ConglomeratesFinance Blue Water Acquisition Corp. II is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Hernandez and is headquartered in Greenwich, CT. | Financial Conglomerates | Director/Board Member | |
| Sackler School of Medicine | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 44 |
| Israel | 2 |
Sektoral
| Health Technology | 19 |
| Consumer Services | 9 |
| Commercial Services | 8 |
| Health Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 83 |
| Corporate Officer/Principal | 58 |
| Chief Executive Officer | 24 |
| Independent Dir/Board Member | 23 |
| Founder | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Frank Douglas | 29 |
| James Sapirstein | 26 |
| Julie Kampf | 21 |
| Shalom Hirschman | 18 |
| Wayne Danson | 17 |
| June Almenoff | 14 |
| Thomas M. Riedhammer | 13 |
| Orin Hirschman | 12 |
| Jason Scott Slakter | 11 |
| Andrew Limpert | 10 |
| Peter K. Kaiser | 9 |
| Samuel Backenroth | 8 |
| Eli Goldberger | 7 |
| Avner Ingerman | 6 |
| Glenn L. Stoller | 6 |
- Börse
- Insiders
- Irach Taraporewala
- Unternehmensverbindungen
